Affinity maturation of humanized anti-epidermal growth factor receptor antibody using a modified phage-based open sandwich selection method

被引:4
|
作者
Sanada, Hideaki [1 ]
Kobayashi, Kazuki [1 ]
Oyama, Kenji [1 ]
Maru, Takamitsu [1 ]
Nakanishi, Takeshi [1 ]
Umetsu, Mitsuo [1 ]
Asano, Ryutaro [1 ,2 ]
Kumagai, Izumi [1 ]
机构
[1] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan
[2] Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Biotechnol & Life Sci, Tokyo 1848588, Japan
来源
SCIENTIFIC REPORTS | 2018年 / 8卷
关键词
RESHAPING HUMAN-ANTIBODIES; BISPECIFIC ANTIBODY; THERMODYNAMIC CONSEQUENCES; CANCER-IMMUNOTHERAPY; MONOCLONAL-ANTIBODY; DISPLAY SYSTEM; DOMAIN ORDER; DIABODY; EGFR; STABILIZATION;
D O I
10.1038/s41598-018-23796-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Affinity maturation is one of the cardinal strategies for improving antibody function using in vitro evolutionary methods; one such well-established method is phage display. To minimise gene deletion, we previously developed an open sandwich (OS) method wherein selection was performed using only phage-displaying VH fragments after mixing with soluble VL fragments. The decrease in anti-EGFR antibody 528 affinity through humanization was successfully recovered by selecting VH mutants using this OS method. However, the affinity was not similar to that of parental 528. For further affinity maturation, we aimed to isolate VL mutants that act in synergy with VH mutants. However, the OS method could not be applied for selecting VL fragments because the preparation of soluble VH fragments was hampered by their instability and insolubility. Therefore, we initially designed a modified OS method based on domain-swapping of VH fragments, from added soluble Fv fragments to phagedisplaying VL fragments. Using this novel Fv-added OS selection method, we successfully isolated VL mutants, and one of the Fv comprising VH and VL mutants showed affinity almost equivalent to that of parental 528. This method is applicable for engineering other VL fragments for affinity maturation.
引用
收藏
页数:9
相关论文
共 45 条
  • [11] Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody
    Foon, KA
    Yang, XD
    Weiner, LM
    Belldegrun, AS
    Figlin, RA
    Crawford, J
    Rowinsky, EK
    Dutcher, JP
    Vogelzang, NJ
    Gollub, J
    Thompson, JA
    Schwartz, G
    Bukowski, RM
    Roskos, LK
    Schwab, GM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (03): : 984 - 990
  • [12] Isolation of a human anti-epidermal growth factor receptor Fab antibody, EG-19-11, with subnanomolar affinity from naive immunoglobulin repertoires using a hierarchical antibody library system
    Hur, Byung-ung
    Yoon, Jae-bong
    Liu, Li-Kun
    Cha, Sang-hoon
    IMMUNOLOGY LETTERS, 2010, 134 (01) : 55 - 61
  • [13] Paper Title “Hu7CG2: A Novel Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Biparatopic Nanobody”
    Jafar Sharifi
    Mohammad Reza Khirehgesh
    Bahman Akbari
    Bijan Soleymani
    Kamran Mansouri
    Molecular Biotechnology, 2021, 63 : 525 - 533
  • [14] IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer
    Herbst, RS
    Kim, ES
    Harari, PM
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2001, 1 (04) : 719 - 732
  • [15] Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer
    Takahashi, Naoki
    Yamada, Yasuhide
    Furuta, Koh
    Nagashima, Kengo
    Kubo, Akiko
    Sasaki, Yusuke
    Shoji, Hirokazu
    Honma, Yoshitaka
    Iwasa, Satoru
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Hamaguchi, Tetsuya
    Shimada, Yasuhiro
    CANCER SCIENCE, 2015, 106 (05) : 604 - 610
  • [16] Sym004: A Novel Synergistic Anti-Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer Efficacy
    Pedersen, Mikkel Wandahl
    Jacobsen, Helle Jane
    Koefoed, Klaus
    Hey, Adam
    Pyke, Charles
    Haurum, John Sorensen
    Kragh, Michael
    CANCER RESEARCH, 2010, 70 (02) : 588 - 597
  • [17] Paper Title "Hu7CG2: A Novel Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Biparatopic Nanobody"
    Sharifi, Jafar
    Khirehgesh, Mohammad Reza
    Akbari, Bahman
    Soleymani, Bijan
    Mansouri, Kamran
    MOLECULAR BIOTECHNOLOGY, 2021, 63 (06) : 525 - 533
  • [18] Anti-epidermal growth factor receptor monoclonal antibody cetuximab augments radiation effects in glioblastoma multiforme in vitro and in vivo
    Eller, JL
    Longo, SL
    Kyle, MM
    Bassano, D
    Hicklin, DJ
    Canute, GW
    NEUROSURGERY, 2005, 56 (01) : 155 - 162
  • [19] Multiplexed Analysis for Anti-Epidermal Growth Factor Receptor Tumor Cell Growth Inhibition Based on Quantum Dot Probes
    Ren, Dahai
    Xia, Yiqiu
    Wang, Bin
    You, Zheng
    ANALYTICAL CHEMISTRY, 2016, 88 (08) : 4318 - 4327
  • [20] Multiple dose toxicity study of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 intravenously administered to Cercopithecus aethiops sabaeus monkeys
    Arteaga-Pérez, ME
    Maceira, M
    Casacó, A
    Hernández-Sosa, O
    Bada-Barro, AM
    León-Goñí, A
    Orpheé-Suárez, R
    Cuevas-Fiallo, A
    Moreno-Díaz, D
    Padro-Gutiérrez, P
    Baro-González, F
    Rodríguez-Rodríguez, V
    Charoo-Ruiz, L
    Vázquez-Castro, F
    Ballester-Labrada, A
    Cedeño, M
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2004, 23 (05) : 219 - 227